Dr. Ismail Nahed

Dr. Ismail Nahed

MD,PhD

Pathology, University of Pittsburgh
3550 Terrace St, Pittsburgh, United States of America, 15261

plus Speciality

Clinical Microbiology

Biography:

EDUCATION and TRAINING
UNDERGRADUATE:
1. 1982-1988: Tanta Faculty of Medicine Tanta University, Egypt

GRADUATE/POST-GRADUATE:
1. 1993- 1995: Dept. of Microbiology&Immunology Institute of Medical Science; University of Toronto; Toronto, Canada
2. 1996- 2000: Dept. of Microbiology&Immunology; University of Saskatchewan Saskatoon, SK, Canada

POSTGRADUATE:
1. 1989-1990: Tanta University Hospitals Tanta, Egypt, Intern Medicine  
2. 1991- 1992: Tanta University Hospitals Tanta,Egypt, Resident Diagnostic (Incomplete) Radiology
3. 1992-1993: Dept. of Medical Microbiology post-doct fellow  Turku University,Finland Microbiology
4. 2000- 2002: Department of Pathology U. of Texas Medical Branch Galveston, TX Atraining,
5. 2002: Clinical Microbiology

SERVICE:
COMMITTES
NATIONAL Member of the American Society for Rickettsiology 2010-Meeting Planning
Committee
INTERNATIONAL Abstracts and Oral Presentations Selection Committe

INSTITUTION:
1. October 2008-2011: Member, Institution Safety Committee Meharry Medical College,
Nashville, TN.
2. August 2010-2011: Member, Student Research Day Speaker Selection Committee Meharry Medical College, Nashville, TN
3. 2010-2011 Member, RCMI 2010 Symposium abstract and oral presentations selection
committees. Meharry Medical College, Nashville, TN.
4. September 2010-2011: Member, Internal Advisory Committee Research Centers in
Minority Institution (RCMI) program Meharry Medical College, Nashville, TN
5. 2005-2008: Medical Students Course Committee, UTMB, Galveston Member, Pathobiology and Host Defense Course Committee Member, Microbiology and Immunology subcommittee of Pathobiology and Host Defense course committee
6. 2004-2005 Scientific Grant Review Committee, UTMB, Galveston McLaughlin Postdoctoral Fellowship Funds Institute for Human Infections and Immunity University of Texas Medical Branch Galveston, TX

DEPARTMENTAL:
1. 2010-2011 Chair, APT committee, Department of Pathology Meharry Medical College, Nashville, TN
2. 2005-2008 Director, Safety Committee, Department of Pathology, Clinical Pathology Services, University of Texas Medical branch, Galveston, TX
3. 2003-2008 Member, Pathology Quality Management Committee Department of Pathology, Pathology Clinical Services University of Texas Medical Branch, Galveston, TX
4. 2007- 2008 Search Committee for Director of Clinical Microbiology Laboratory, Department of Pathology, UTMB, Galveston
5. 2007-2008 Member, Laboratory Automation Committee Department of Pathology, Clinical Pathology Services University of Texas Medical Branch, Galveston, TX
6. 2008 Member, Educational Internal Review Committee Department of Pathology University of Texas Medical Branch, Galveston, TX
7. 2006, 2007 Director of Medical Student Elective Program in Clinical Microbiology,
University of Texas Medical Branch, Galveston, TX
8. 2005 Member, Faculty Compensation Committee Department of Pathology University of Texas Medical Branch, Galveston, TX

Academic positions:

APPOINTMENTS and POSITIONS ACADEMIC:
1. 2003-2004: Dept. of Pathology, University of Texas Medical Branch (UTMB), Galveston, TX as Instructor.
2. 2004-2008: Dept. of Pathology, University of Texas Medical Branch (UTMB), Galveston, TX as Assistant Professor
March2008-August2008: Dept. of Pathology, University of Texas Medical Branch (UTMB), Galveston, TX as Associate Professor
3. 2002-2006: Laboratory Medicine, Division of Clinical Microbiology, Dept. of Pathology, University of Texas Medical Branch (UTMB), Galveston, TX as Assistant Director
4. 2006-2008: Laboratory Medicine, Division of Clinical Microbiology, Dept. of Pathology, University of Texas Medical Branch (UTMB), Galveston, TX as Associate Director
5. 2005-2007: Clinical Immunology, Serology and Virology Sections, Division of Clinical Microbiology, Dept. of Pathology, University of Texas Medical Branch (UTMB),Galveston, TX as Section Director
6. 2007-2008: Bacteriology and Parasitology Sections, Division of  Clinical Microbiology, Dept. of Pathology, University of Texas Medical Branch (UTMB), Galveston, TX
7. 2003-2008: Sealy Center for Vaccine Development & Center for Biodefense and Emerging Infectious Disease University of Texas Medical Branch, Galveston, TX as Member
8. 2008-2011: Department of Pathology, and Department of Microbiology and Immunology, Meharry Medical College, Nashville, TN as Associate Professor
9. 2008-2010: Vanderbilt Institute of Clinical &Translational Research, Vanderbilt-Meharry Alliance, Nashville, TN as Director, Oral Pathogen Core
10. 2010-2011: Meharry Clinical and Translational Research Center. Meharry Medical College, Nashville, TN as Director, Female Tissue Acquisition Core
11. 2008-2011: Center for Women’s Heath Research, Meharry Medical College, Nashville, TN as Member
12. 2011 – present: Department of Pathology; University of Pittsburgh; Pittsburgh PA as Visiting Associate Professor of Pathology
13. 2011-Present : Magee Women Hospital Clinical Microbiology and Immunology Lab University of Pittsburgh Medical Center as Medical Director

CERTIFICATION and LICENSURE
2008-present: American Board of Medical Microbiology (ABMM)
2008-2011: Specialist in Microbiology (SM), Board of Registry, American Society for
Clinical Pathology (SM, ASCP)
2010-present: American Board of Medical Laboratory Immunology (ABMLI)

MEDICAL or OTHER PROFESSIONAL LICENSURE
1988-present: Permanent Medical License, Ministry of Health, Egypt.

MEMBERSHIPS in PROFESSIONAL and SCIENTIFIC SOCIETIES:
1996-2000, 2004-2006 , 2008-present: Association of Immunologists (AAI)
2007, 2008: Association of Medical laboratory Immunologists (AMLI)
2007-present: American Society for Rickettsiology (ASR)
2000-present: American Society of Microbiology (ASM), Division C.
2001-2004: American Society of Tropical Medicine and Hygiene  
1997-2001:Canadian Society of Immunology (CSI)
1990-1991: Nordic Molecular Biology Association (NOMBA)
1990-1992: Turku Microbiological Society, Turku, Finland

HONORS/AWARDS:
1. 2012-2013: Chair-Elect for Division “V” (Clinical and Diagnostic Immunology) of the
American Society of Microbiology (ASM).
2. 2011: Member, the American Board of Medical laboratory Immunology
Exam Validation committee.
3. 2011: Editor, for  the American Society of Microbiology, Clinical Microbiology, Portal’s Questions & Answers Committee
4. 2011: Invited Speaker, 6th international conferences on Rickettsia and Rickettsial Diseases
5. 2010: Invited Speaker, Institute of Medicine, national Academy of Science: Workshop on: Critical Needs and  Gaps in Understanding Prevention, Amelioration, and  Resolution of Lyme and  Other Tick-Borne Diseases: The Short-Term and Long-Term Outcomes
6. 2009: Editorial selection of our paper entitled “Persistent infection contributes to Heterologous protective immunity against fatal ehrlichiosis” for the SPOTLIGHT section in Infection  and Immunity.
7. 2006: Excellence in Teaching Award, Experimental Pathology Graduate program, University of Texas Graduate School of Biomedical Sciences
8. 2006: Nominated for the 2006 Graduate Student Organization (GSO) Teacher Student Advocacy Award.
9.2002: First Place in postdoctoral fellow award for mechanistic and basic research, Department of Pathology annual Research Day, University of Texas Medical Branch, Galveston, Texas, USA.
10.1998: College of Medicine First Prize, Best Poster Award, Annual Research Day,
University of Saskatchewan, Saskatoon, Sask., Canada.
11. 1993-1995: University of Toronto Open Research Fellowship, University of Toronto, Toronto, Canada.
12. 1996-2001: College of Medicine Graduate Scholarships, University of Saskatchewan,  Saskatoon, Sask, Canada.

Research interests:

Clinical Research Interest,Basic Research Interest,Bacteriology and Parasitology

Any other information:

1. Power, C. A., C. L. Grand, N. Ismail, N. C. Peters, D. P. Yurkowski, and P. A. Bretscher. A valid ELISPOT assay for enumeration of ex vivo, antigen-specific IFN-gamma producing cells. J. Immunol. Methods. 227:99-107, 1999.
2. Ismail N., and P. A. Bretscher. The Th1/Th2 nature of concurrent immune responses to unrelated antigens can be independently determined. The Journal of Immunology.
163: 4842-50, 1999.
3. Bretscher, P. A., N. Ismail, J. N. Menon, C. A. Power, J. Uzonna, and G. Wei. Vaccination against and treatment of chronic diseases caused by intracellular pathogens: a perspective from studies in basic immunology, immunity in tuberculosis, and leishmaniasis and AIDS. Cellular and Molecular Life Science 58:1879-1896, 2001.
4. Ismail, N., and B. Reisner. Update on Respiratory Syncytial virus. Clinical Microbiology Newsletter 23: 91-97, 2001.
5. Bretscher, P. A., N. Ismail, N. C. Peters, and J. Uzonna. Cell-to-cell interactions and signaling within the immune system: Towards integrating mechanisms and physiology. New Foundation of Biology; Berczi I., and Gorezynski, R. M. Elsevier Science B.V, 2001.
6. Ismail N., and P. A. Bretscher. More antigen-dependent CD4+ T cell/ CD4+ T cell interactions are required for the primary generation of Th2 than Th1 cells. European Journal of Immunology 31:1765-71, 2002.  
7. Ismail, N., Juan P. Olano, Hui-Min Feng, and David H. Walker. Current status of immune mechanisms of killing of intracellular pathogens. FEMS Microbiology Letters 207:111-120, 2002.
8. Ismail, N., G. E. Fish, and M. B Smith. Laboratory evaluation of a fully-automated chemiluminescence immunoassay for rapid detection of Hepatitis B surface antigen (HBsAg), antibodies to HBsAg and antibodies to Hepatitis C virus, Journal of Clinical Microbiology 42:610-617, 2004.
9. Walker, D. H., N. Ismail, J. P. Olano, J. W. McBride, X. J. Yu, and H-M, Feng. Ehrlichia chaffeenesis: A prevalent, life threatening, emerging pathogen. Transactions of the American Clinical and Climatological Association 115: 375-384, 2004.
10. Ismail, N., L. Soong, J. W. McBride, G. Valbuena, J. P. Olano, H-M, Feng, and D.H. Walker. Overproduction of TNF alpha by CD8+ type-1 cells and down regulation of IFN-gamma ?production by CD4+ Th1 cells contribute to toxic shock like syndrome in an animal model of fatal monocytotropic ehrlichiosis. The Journal of Immunology 172: 1786-800, 2004.
11. Ismail, N., B. Anthony, H. Briscoe, and P. Bretscher. Increasing the foreignness of an antigen, by coupling a second and foreign antigen to it, increases the Th2 component of the immune response to the first antigen. Immunology 115:34-41, 2005.
12. Mattner, J., K. L. DeBord, N. Ismail, D. Zhou, C. Cantu III, P. S.Mezard, V. Wang, K. Hoebe, O. Schneewind, D. H. Walker, B. Beutler, L.Teyton, P. B. Savage, A. Bendelac. Both exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434:525-9, 2005.
13. Ismail, N., and D. H. Walker. Balancing protective immunity and immunopathology: A Unifying model of monocytotropic ehrlichiosis. Annals of the New York Academy of Science 1063:420-4, 2005.
14. Sousa, R. D., N. Ismail, S. D. Nobrega, P. Costa,  T. Abreu, A. Franca,  M. Amaro, P. Proenca, P. Brito, J. Pocas, T. Ramos, G. Cristina, G. Pombo, L. Vitorino, J. Torgal, F. Bacellar, and D. H. Walker. The presence of Eschars in Portuguese patients infected with Israeli tick typhus strain of Rickettsia conorii. Annals of the New York Acad. of Science 1063:197-202, 2005.
15. Crocquet-Valdes, P.A., J. M. Mcbride, H-M Feng, N. Ismail, A. M. Small, X-J Yu and D. H. Walker. Analysis of ehrlichial P28 gene expression in a murine model of persistent infection. Annals of the New York Academy of Science 1063:420-4, 2005.
16. Walker, D. H., N. Ismail, J. P. Olano, G. Valbuena, and J. W. McBride. Pathogenesis, immunity, pathology, and pathophysiology in rickettsial diseases” Rickettsial Diseases: Old and New, Raoult and Parola, Marcel Dekker Inc, 2006.
17. Ismail, N., H. L. Stevenson, and D. H. Walker. The Role of TNF-alpha ?and IL-10 ?in the pathogenesis of severe murine monocytotropic ehrlichiosis: Increased resistance of TNF receptor p55- and p75-deficient mice to fatal ehrlichial infection. Infection and Immunity 74: 1846-56, 2006.
18. Stevenson, S. L., Z. Peerwani, J. M. Jordan, H. Q. Wang, D. H. Walker, and N. Ismail. An intradermal environment promotes a protective type-1 response against monocytotropic Ehrlichia. Infection and Immunity 74:4856-64, 2006.
19. Stevenson, H. L., N.  Ismail and D. H. Walker. Ehrlichiae and ehrlichiosis: Pathogenesis and vector biology. National Institute of Allergy and Infectious Disease: Progress in Research, 2006.    
20. Essam, A., S. A., Salama, N. Ismail, and A. Al-Hendy. Towards gene therapy of endometriosis: Adenovirus-mediated delivery of dominant negative estrogen receptor gene inhibits cell proliferation, reduces cytokine production, and induces apoptosis of endometriotic cells. Fertility and Sterility 88:462-7, 2007.
21. LaSala, P. R., C. Sanders, K. K. Bufton, N. Ismail, and M. B. Smith. Prospective comparison of R-mix™ shell vial system with direct antigen tests and conventional cell culture for respiratory virus detection. Journal of Clinical Virology 38:210-6, 2007.
22. Fang, R., N.  Ismail, L.Soong, V. L. Popov, T. Whitworth, D. H. Bouyer, and D. H. Walker. Differential interaction of dendritic cells with Rickettsia: impact on host susceptibilities to murine spotted fever rickettsiosis, Infection and Immunity 75:3112-23, 2007.
23. Ismail, N., Stevenson, H. L., E. C. Crossley, and D. H. Walker. The relative importance of T cell subsets in immunity and immunopathology of monocytotropic ehrlichiosis: A novel effector mechanism involved in Ehrlichia-induced immunopathology in murine ehrlichiosis. Infection and Immunity 75:4608-20, 2007.
24. Sousa, R. D.,  N. Ismail?, S. D. Nobrega,  A. Franca, M. Amaro, M. Anes, J.Pocas, R. Coelho, J. Torgal, F. Bacellar, and D. H. Walker. Intralesional IFN-γ, TNF-α, IL-10, iNOS, indoleamine-2, 3-dioxygenase, and RANTES are major immune effectors in Mediterranean spotted fever rickettsiosis. ?First & second Authors contributed equally, Journal of Infectious Diseases 196:770-81, 2007.
25. Walker, D. H., N. Ismail, and X-J Yu.  Vaccines against rickettsial infections, In Vaccines against biothreat and Emerging Infectious Diseases”, Elsevier, 2007.
26. Stevenson, H. L., D. H. Walker, and N. Ismail: Regulatory role of CD1d-restricted NKT cells in the induction of toxic shock-like syndrome in an animal model of fatal ehrlichiosis. Infection and Immunity, 76:1434-44, 2008.
27. Thirumalapura, R. N., D. H. Walker, and N. Ismail:  Protective heterologous immunity against fatal ehrlichiosis and lack of protection following homologous challenge. Infection and Immunity, 76:1920-30, 2008.
28. Walker, D. H., and N. Ismail: Rickettsiosis: Emerging and re-emerging endothelial infection and early disease events. Nature Reviews Microbiology, 6:375-86, 2008.
29. Sousa, R. D., A. Franco, S. Doria, M. Amaro, T. Abreu, J. Pocas, P. Proenca, R. Coelho, J. Vaz, J. Torgal, F. Bacellar, N. Ismail, D. H. Walker. Host and microbial risk factors and pathophysiology of fatal Rickettsia conorii infection in Portuguese patients. Journal of Infectious Disease, 198:576-85, 2008.
30. Rapose, A., S. D. Lick, and N. Ismail. Listeria grayi in a heart transplant. Transplant infectious disease, 10:434-6, 2008.
31. Thomas, S., N. R. Thirumalapura, E. C. Crossley, N. Ismail, and D. H. Walker. Antigenic protein modifications in Ehrlichia, Parasite Immunology, 31:296-303, 2009.
32. Duane Hamilton, N. Ismail, D. Kroeger, C. Rudulier, and P. Bretscher. Macroimmunology and immunotherapy of cancer. Immunotherapy, 31:296-303, 2009.
33. Fang, R., N. Ismail, and D. H. Walker. CD4+CD25+ Foxp3-CTLA-4+ T regulatory cells are the major source of IFN-gamma ?and IL-10 in acute fatal rickettsial infection. Infection and Immunity, 77:3838-49, 2009.
34. Thirumalapura, N. R., E.C. Crossley, D. H. Walker, and N.  Ismail.  Persistent infection contributes to heterologous protective immunity against fatal ehrlichiosis. Infection and Immunity, 77:5582-9, 2009.
35. Stevenson, H.L., D. M. Estes, R. N. Thirumalapura, D. H. Walker, and N. Ismail. Natural Killer Cells Promote Tissue Injury and Systemic Inflammatory Responses during Fatal Ehrlichia-Induced Toxic Shock-like Syndrome. American Journal of Pathology, 177: 766-776, 2010.
36. Ismail, H., M. Soliman, and N. Ismail. Occult Hepatitis B Virus Infection in Hemodialysis Egyptian Patients with or without Hepatitis C virus Infection. Open Access Pathology and Laboratory Medicine International, 2:113-120, 2010.
37. Ghose, P., A. Q. Ali, R. Fang, D. Forbes, B. Ballard, and N. Ismail. The interaction between IL-18 and IL-18R limits the magnitude of protective immunity and enhances pathogenic responses following infection with intracellular bacteria. J. Immunol. 187:1333-46, 2011.
38. Ghose, P., and N. Ismail The Interaction between IL-18 and IL-18 Receptor Limits the Magnitude of Protective Immunity and Enhances Pathogenic Responses following Infection with Intracellular Bacteria. Protein Disease case report – Highlighted by Target Intelligence service, 2011.
39.Valdes, P., N. R. Thirumalapura, N. Ismail, X-j, Yu, H. L. Stevenson, C. Pietzche, S. Thomas and D. H. Walker. Immunization with Ehrlichia outer membrane P28 proteins confers protection in a mouse model of ehrlichiosis. Clinical Vaccine Immunology. 18:2018-25, 2011.
40. Fang, R., N. Ismail, and D. H. Walker. NK cells contribute greatly to host innate resistance to murine spotted fever rickettsiosis. Favorable Review, Am. J.  Pathology, 2011.
41. Ismail, N., D. H. Walker, P. Ghose, and Yi-W. Tang. Immune Mediators of Protective and Pathogenic Immune Responses in Patients with Mild and Fatal Human Monocytotropic Ehrlichiosis. Favorable review, BMC Immunology, 2012.

What I think of the idea behind WebmedCentral and WebmedCentral plus:

WebmedCentral encourages open peer-review and allow the publication of manuscript in a timely and fast manner with no or little initial restriction.